|Day Low/High||37.09 / 37.28|
|52 Wk Low/High||28.19 / 38.61|
Philips said it doesn't know if Third Point has taken stake
Combination of innovation and expertise better enables health systems to meet regulatory compliance while managing radiation doses for patients
92 percent of the U.S. COPD patients studied did not receive PAP therapy despite possible benefits
U.S. stock futures point to a mixed start for Wall Street on Wednesday, June 28.
Royal Philips said Wednesday that it will buy medical devices maker Spectranetics Corporation in a deal that carries an enterprise value of around €1.9 billion.
Enhanced applications for neurology, cardiology and oncology help clinicians analyze and compare medical images, evaluate treatment options, and track therapy response over time
Showcases continued commitment to creating innovative solutions that enhance and simplify the clinical decision making path, from diagnosis to treatment, to drive more personalized care
Former Olympic gold medalist, David Plummer, joins Philips to discuss his journey with sleep apnea treatment
- Debuts IntelliSpace Oncology, an integrated oncology informatics solution enabling data-driven decision making and proactive patient involvement across care teams
- New "turnkey" approach to precision medicine seeks to deliver Intermountain's best practices into a streamlined service to be integrated at the point of care
- Agreement aims to enable precision diagnostics for pancreatic cancer by developing new methods* to resolve single-cell level differences within and between tumors
Study showed use of home non-invasive ventilation in conjunction with home oxygen therapy delayed hospital readmissions for patients with advanced disease
Royal Philips (NYSE:PHG, AEX:PHIA) today announced the results of its second annual Future Health Index (FHI), an international study of the general population and healthcare professionals that examines their views...
Philips TrueVue, GlassVue and aReveal(A.I.) improve workflow and diagnostic confidence, enhancing the connection between clinicians and their patients
Van Houten was speaking at the World Medical Innovation Forum in Boston.
Researchers find automated 3D Echocardiographic analysis of left-heart chambers an accurate alternative to manual methodology
The Dutch medical devices makers is up more than 3% after first quarter cost savings helped it to beat net income expectations by about 50%.
Highlights work with the University of Vermont to advance neuro imaging with Philips' newest neurological clinical application, MultiBand SENSE
Multifaceted approach to treatment offers significant financial benefits while improving quality of patient care
- First digital pathology solution to be cleared for primary diagnostic use in the U.S.
Advanced CPAP offers same clinically-proven therapy as Philips' award-winning DreamStation at half the size for reliable, uninterrupted therapy while on-the-go
Leading healthcare organization implements population health management tools to reduce hospital stays and readmission, eases the burden of critical care shortage